Life Sciences Consulting for Enterprises & Investors

image of a mid century modern tv
image of a mid century modern tv

In the Pipeline:

  • European Growth: Helping an EU-based startup hub with fundraising, product roadmaps, and the regulatory maze that comes with scaling in Europe

  • Grant applications (NIH, NSF): Developing SBIR, R21, and R01 applications for upcoming funding rounds

  • Diagnostic devices: Working with a US big data startup to bring an early-stage cancer detection system from prototype to launch

  • Environmental Law: Exploring the legal dimensions of pollution-linked Public Health impact

  • Land Conservation: Fundraising for habitat creation and conservation projects

"Anubis BioConsulting was instrumental in developing our report on the role of stakeholders in corporate sustainability."

Corporate Attorney - Rome

"This is a much better pitch! Well done! I'm excited to see how this might shift the conversations..."

Founder and branding specialist - Washington

We work alongside EU-based attorneys and law firms on ESG compliance, sustainability strategy, and public health. Because the regulatory side of life sciences doesn't stop at the lab door...

We help people build the next generation of biotech, medtech, and pharma companies. And we assist the private equity firms, VCs, and strategic investors backing them to make smarter bets through rigorous due diligence.

What people say about us:

At Anubis BioConsulting, we help science-driven companies turn breakthrough research into fundable, launchable ventures. From strategy and roadmapping to clinical and regulatory pathways, FDA/EMA submissions, grants, IP strategy, and investor-ready pitch decks — our team partners with biotech, medtech, and pharma founders to navigate the complexities of bringing innovation to market. Bridging science, innovation, and capital, we help you stay compliant, look fundable, and get to market faster.

a tag that reads "for enterprises"
a tag that reads "for enterprises"

We provide rigorous life sciences due diligence for private equity firms, venture capital funds, and strategic investors evaluating biotech, medtech, and pharma opportunities. From competitive intelligence and market analysis to IP review, FDA/EMA regulatory navigation, and technology assessment, our team delivers evidence-based insights — backed by a trusted network of KOLs and domain specialists. Bridging science, innovation, and capital, we bring lab-level understanding to your investment process so you can invest with clarity, not just conviction.

a label that reads "for investors"
a label that reads "for investors"

Partners & Collaborators:

Interested in collaborating with us?

Drop us a line at: info@anubisbc.com
Or fill out our contact form for a free chat:

Anubis BioConsulting